<DOC>
	<DOCNO>NCT02169076</DOCNO>
	<brief_summary>Left Ventricular Assist Devices ( LVAD ) mechanical heart pump increasingly implanted patient severe heart failure fail medical therapy . In patient LVADs , right ventricular failure , support LVAD pump , major problem affect quality-of-life survival . Cardiac Resynchronization Therapy ( CRT ) aim restore synchronized contraction heart prove beneficial improve ejection fraction right leave ventricle well quality life select heart failure patient . The role CRT patient LVADs unknown . We hypothesize CRT exert beneficial impact right ventricular function LVAD patient improve quality-of-life . The specific question study aim answer : 1 . What effect CRT function non-supported right ventricle patient implant LVAD ? 2 . Can effect CRT cardiac function positively impact quality-of-life exercise capacity LVAD recipient ? In study patient previously implant CRT device , later receive LVAD , randomly assign CRT turn ( CRT-off ) ( CRT-on ) . The patient follow 8-week period , switch opposite CRT status . The total participation study last 16 ± 1 week , involve 3 clinic visit approximately 3 hour duration ( initial visit , 8 week visit , 16 week final visit ) , plus 2 quick check pacemaker/defibrillator in-between visit . Heart function assess comprehensive echocardiographic study CRT `` '' CRT `` '' period . Quality-of-life exercise capacity assess standardized questionnaire 6-Minute Walk Test .</brief_summary>
	<brief_title>Impact Cardiac Resynchronization Therapy Right Ventricular Function Left Ventricular Assist Device Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Heart failure patient previously implant BiVentricular pacemaker / defibrillator , continuous flow LVAD ( Heart Mate II® HeartWare® ) The LVAD must implant 8 week 18 month prior enrollment Patients least 3 week post discharge LVAD implant hospitalization Severe decompensated right ventricular failure define require follow : Hospitalization heart failure within last 30 day Need inotropic infusion &gt; 48h within last 14 day Increase &gt; 100 % diuretic dose within last 14 day Severe aortic regurgitation document echocardiography cardiac catheterization Stage IV great kidney disease ( GFR &lt; 30 mL/min/1.73 m2 ) Active infection ( include control chronic driveline infection suppressive antibiotic therapy ) Biventricular pace &lt; 90 % time due uncontrolled arrhythmia LVAD malfunction Inability follow study protocol Nonfunctional LV lead ( i.e . high capture threshold correct programming change )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Ventricular Assist Device , Cardiac Resynchronization Therapy</keyword>
</DOC>